SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5fl7'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DIT_P_2PPP1_1 (ALPHA-THROMBIN PEPTIDE INHIBITOR CVS995)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	4 / 6	LEU D 445 ILE D 375 ASP D 380 PRO D 381	None	1.20A	1ditH-5fl7D: 0.5 1ditP-5fl7D: undetectable	1ditH-5fl7D: 18.07 1ditP-5fl7D: 3.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KT4_A_RTLA184_0 (PLASMA RETINOL-BINDING PROTEIN)	5fl7	ATP SYNTHASE SUBUNIT ALPHA ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica; Yarrowia lipolytica)	5 / 12	LEU D 382 ALA D 179 ALA D 362 GLN D 406 ARG A 388	None	1.25A	1kt4A-5fl7D: undetectable	1kt4A-5fl7D: 16.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1P6K_A_ACTA860_0 (NITRIC-OXIDE SYNTHASE, BRAIN)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	4 / 6	GLY A 98 GLN A 96 VAL A 57 ALA A 65	None	0.99A	1p6kA-5fl7A: undetectable	1p6kA-5fl7A: 19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RMT_D_ADND1504_1 (CLASS B ACID PHOSPHATASE)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	4 / 8	ASP D 380 LEU D 348 ASP D 346 THR D 363	None	0.86A	1rmtD-5fl7D: undetectable	1rmtD-5fl7D: 20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XL6_B_SPMB3001_1 (INWARD RECTIFIER POTASSIUM CHANNEL)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	4 / 5	TYR A 304 ALA A 266 TYR A 270 GLN A 156	None	1.12A	1xl6A-5fl7A: undetectable 1xl6B-5fl7A: undetectable	1xl6A-5fl7A: 21.10 1xl6B-5fl7A: 21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_B_ROFB501_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	3 / 3	MET A 409 ASN A 211 GLN A 456	None	1.02A	1xoqB-5fl7A: undetectable	1xoqB-5fl7A: 21.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FXD_A_DR7A102_2 (POL PROTEIN)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	4 / 7	ALA A 251 ASP A 250 GLY A 131 ILE A 256	None	0.74A	2fxdB-5fl7A: undetectable	2fxdB-5fl7A: 10.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q7K_A_TESA304_1 (ANDROGEN RECEPTOR)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	5 / 12	LEU A 271 LEU A 268 MET A 307 VAL A 100 LEU A 90	None	1.31A	2q7kA-5fl7A: undetectable	2q7kA-5fl7A: 19.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q8H_A_TF4A438_1 ([PYRUVATE DEHYDROGENASE [LIPOAMIDE]] KINASE ISOZYME 1)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 6	LEU D 248 ILE D 238 ARG D 125 ILE D 126 ARG D 137	None	1.49A	2q8hA-5fl7D: undetectable	2q8hA-5fl7D: 22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V0Z_O_C41O1327_2 (RENIN)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	4 / 8	SER A 396 THR A 372 PRO A 351 LEU A 297	None	1.10A	2v0zO-5fl7A: undetectable	2v0zO-5fl7A: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WEK_A_DIFA1375_1 (ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING PROTEIN 2)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	3 / 3	LEU D 409 TYR D 412 GLN D 416	None	0.75A	2wekA-5fl7D: undetectable	2wekA-5fl7D: 24.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZJ0_A_2FAA500_2 (ADENOSYLHOMOCYSTEINA SE)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	4 / 5	GLN D 313 THR D 315 HIS D 149 LEU D 265	None	1.38A	2zj0A-5fl7D: undetectable	2zj0A-5fl7D: 23.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A51_B_VDYB6178_1 (VITAMIN D HYDROXYLASE)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	5 / 12	THR A 372 LEU A 332 ILE A 353 VAL A 232 PRO A 273	None	1.42A	3a51B-5fl7A: undetectable	3a51B-5fl7A: 21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BGD_A_PM6A302_1 (THIOPURINE S-METHYLTRANSFERASE)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	4 / 6	THR A 174 GLN A 212 LEU A 350 LEU A 291	None	1.15A	3bgdA-5fl7A: 2.9	3bgdA-5fl7A: 18.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3E9X_A_NIMA1_1 (LACTOTRANSFERRIN')	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	4 / 4	GLU D 200 GLY D 168 THR D 167 GLU D 166	None	1.08A	3e9xA-5fl7D: undetectable	3e9xA-5fl7D: 21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HJO_A_EAAA211_1 (GLUTATHIONE S-TRANSFERASE P)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	4 / 8	VAL D 214 VAL D 118 ILE D 327 GLY D 267	None	0.95A	3hjoA-5fl7D: undetectable	3hjoA-5fl7D: 20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3K37_A_BCZA468_1 (NEURAMINIDASE)	5fl7	ATP SYNTHASE SUBUNIT ALPHA ATP SYNTHASE SUBUNIT BETA ATP SYNTHASE SUBUNIT GAMMA CHAIN, MITOCHONDRIAL (Yarrowia lipolytica; Yarrowia lipolytica; Yarrowia lipolytica)	3 / 3	ASP D 347 ARG G 25 ARG A 197	None	1.03A	3k37A-5fl7D: undetectable	3k37A-5fl7D: 21.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KKZ_B_SAMB302_0 (UNCHARACTERIZED PROTEIN Q5LES9)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 12	GLY D 119 GLY D 267 PHE D 215 LEU D 248 ALA D 271	None	1.09A	3kkzB-5fl7D: undetectable	3kkzB-5fl7D: 19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OWX_B_XRAB233_1 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	5 / 11	VAL A 468 PHE A 494 PHE A 530 GLY A 474 GLY A 477	None	1.37A	3owxA-5fl7A: undetectable 3owxB-5fl7A: undetectable	3owxA-5fl7A: 17.96 3owxB-5fl7A: 17.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QXY_A_SAMA6734_0 (N-LYSINE METHYLTRANSFERASE SETD6)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	5 / 12	VAL A 412 ALA A 413 GLY A 414 ALA A 404 LEU A 515	None	1.18A	3qxyA-5fl7A: undetectable	3qxyA-5fl7A: 23.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RC0_A_SAMA484_0 (N-LYSINE METHYLTRANSFERASE SETD6)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	5 / 11	VAL A 412 ALA A 413 GLY A 414 ALA A 404 LEU A 515	None	1.15A	3rc0A-5fl7A: undetectable	3rc0A-5fl7A: 23.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RC0_B_SAMB480_0 (N-LYSINE METHYLTRANSFERASE SETD6)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	5 / 12	VAL A 412 ALA A 413 GLY A 414 ALA A 404 LEU A 515	None	1.14A	3rc0B-5fl7A: undetectable	3rc0B-5fl7A: 23.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WFA_B_EDTB802_0 (ALPHA-GLUCOSIDASE)	5fl7	ATP SYNTHASE SUBUNIT ALPHA ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica; Yarrowia lipolytica)	4 / 6	ARG A 106 ASP D 109 ASN D 65 LYS A 109	None	1.19A	3wfaA-5fl7A: undetectable 3wfaB-5fl7A: undetectable	3wfaA-5fl7A: 23.06 3wfaB-5fl7A: 23.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WRI_A_CAMA502_0 (CAMPHOR 5-MONOOXYGENASE)	5fl7	ATP SYNTHASE SUBUNIT BETA ATP SYNTHASE SUBUNIT GAMMA CHAIN, MITOCHONDRIAL (Yarrowia lipolytica; Yarrowia lipolytica)	4 / 5	LEU G 292 GLY D 304 ILE D 47 VAL D 50	None	0.80A	3wriA-5fl7G: undetectable	3wriA-5fl7G: 19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WRI_B_CAMB502_0 (CAMPHOR 5-MONOOXYGENASE)	5fl7	ATP SYNTHASE SUBUNIT BETA ATP SYNTHASE SUBUNIT GAMMA CHAIN, MITOCHONDRIAL (Yarrowia lipolytica; Yarrowia lipolytica)	4 / 5	LEU G 292 GLY D 304 ILE D 47 VAL D 50	None	0.81A	3wriB-5fl7G: undetectable	3wriB-5fl7G: 19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WRK_A_CAMA502_0 (CAMPHOR 5-MONOOXYGENASE)	5fl7	ATP SYNTHASE SUBUNIT BETA ATP SYNTHASE SUBUNIT GAMMA CHAIN, MITOCHONDRIAL (Yarrowia lipolytica; Yarrowia lipolytica)	4 / 5	LEU G 292 GLY D 304 ILE D 47 VAL D 50	None	0.83A	3wrkA-5fl7G: undetectable	3wrkA-5fl7G: 19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WRK_D_CAMD502_0 (CAMPHOR 5-MONOOXYGENASE)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	4 / 5	PHE A 294 LEU A 347 GLY A 280 VAL A 258	None	0.94A	3wrkD-5fl7A: undetectable	3wrkD-5fl7A: 21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A9K_A_TYLA2200_1 (CREB-BINDING PROTEIN)	5fl7	ATP SYNTHASE DELTA CHAIN, MITOCHONDRIAL (Yarrowia lipolytica)	4 / 6	VAL H 84 LEU H 50 ILE H 69 VAL H 28	None	0.92A	4a9kA-5fl7H: undetectable	4a9kA-5fl7H: 20.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AN2_A_EUIA1382_2 (DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	4 / 4	ASN D 404 SER D 386 LEU D 389 THR D 408	None	1.36A	4an2A-5fl7D: undetectable	4an2A-5fl7D: 19.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BQF_A_QPSA951_1 (ALPHA-GLUCAN PHOSPHORYLASE 2, CYTOSOLIC)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	4 / 6	MET A 338 GLY A 345 ARG A 165 GLU A 281	None	1.46A	4bqfA-5fl7A: undetectable	4bqfA-5fl7A: 21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EIL_D_FOLD703_0 (BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLAT E SYNTHASE)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 10	VAL D 401 ASP D 477 SER D 471 PHE D 488 VAL D 405	None	1.24A	4eilD-5fl7D: undetectable	4eilD-5fl7D: 24.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FGK_A_0TXA304_0 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	5 / 10	GLY A 474 GLY A 477 VAL A 468 PHE A 494 PHE A 530	None	1.39A	4fgkA-5fl7A: undetectable 4fgkB-5fl7A: undetectable	4fgkA-5fl7A: 17.96 4fgkB-5fl7A: 17.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KYA_B_FOLB703_0 (BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLAT E SYNTHASE)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 12	VAL D 401 ASP D 477 SER D 471 PHE D 488 VAL D 405	None	1.28A	4kyaB-5fl7D: undetectable	4kyaB-5fl7D: 24.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KYA_C_FOLC703_0 (BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLAT E SYNTHASE)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 10	VAL D 401 ASP D 477 SER D 471 PHE D 488 VAL D 405	None	1.34A	4kyaC-5fl7D: undetectable	4kyaC-5fl7D: 24.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KYA_D_FOLD703_0 (BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLAT E SYNTHASE)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 12	VAL D 401 ASP D 477 SER D 471 PHE D 488 VAL D 405	None	1.26A	4kyaD-5fl7D: undetectable	4kyaD-5fl7D: 24.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KYA_F_FOLF703_0 (BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLAT E SYNTHASE)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 12	VAL D 401 ASP D 477 SER D 471 PHE D 488 VAL D 405	None	1.23A	4kyaF-5fl7D: undetectable	4kyaF-5fl7D: 24.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KYA_G_FOLG703_0 (BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLAT E SYNTHASE)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 11	VAL D 401 ASP D 477 SER D 471 PHE D 488 VAL D 405	None	1.34A	4kyaG-5fl7D: undetectable	4kyaG-5fl7D: 24.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O5F_A_PAUA301_0 (TYPE III PANTOTHENATE KINASE)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 12	VAL D 172 LEU D 462 GLY D 168 ASP D 173 ILE D 205	None	1.31A	4o5fA-5fl7D: undetectable 4o5fB-5fl7D: undetectable	4o5fA-5fl7D: 22.76 4o5fB-5fl7D: 22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	5 / 11	SER A 298 THR A 199 THR A 202 GLY A 195 THR A 355	None ATP A 600 (-4.9A) MG A 601 ( 2.8A) None None	1.45A	4qw3V-5fl7A: undetectable 4qw3b-5fl7A: undetectable	4qw3V-5fl7A: 19.84 4qw3b-5fl7A: 16.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_N_BO2N201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	5 / 11	SER A 298 THR A 199 THR A 202 GLY A 195 THR A 355	None ATP A 600 (-4.9A) MG A 601 ( 2.8A) None None	1.46A	4qw3H-5fl7A: undetectable 4qw3N-5fl7A: undetectable	4qw3H-5fl7A: 19.84 4qw3N-5fl7A: 16.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UY8_7_TRP71002_0 (TRYPTOPHANASE)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	4 / 4	ILE D 205 ASN D 204 ILE D 169 VAL D 172	None	1.26A	4uy87-5fl7D: undetectable	4uy87-5fl7D: 9.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP4_A_COCA706_1 (DOPAMINE TRANSPORTER)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 11	ASP D 287 ALA D 340 ASP D 227 GLY D 219 GLY D 225	MG D 601 ( 4.8A) None None None None	1.27A	4xp4A-5fl7D: undetectable	4xp4A-5fl7D: 24.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZJO_A_ERYA1101_0 (MULTIDRUG EFFLUX PUMP SUBUNIT ACRB)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 12	ALA D 295 ASP D 287 GLU D 224 GLU D 220 THR D 195	None MG D 601 ( 4.8A) MG D 601 ( 3.8A) MG D 601 ( 4.9A) MG D 601 ( 3.1A)	1.48A	4zjoA-5fl7D: undetectable	4zjoA-5fl7D: 20.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZVM_B_DM2B303_1 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	5 / 11	VAL A 468 PHE A 494 PHE A 530 GLY A 474 GLY A 477	None	1.34A	4zvmA-5fl7A: undetectable 4zvmB-5fl7A: undetectable	4zvmA-5fl7A: 18.05 4zvmB-5fl7A: 18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5A06_D_SORD1341_0 (ALDOSE-ALDOSE OXIDOREDUCTASE)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	4 / 6	GLU A 379 GLY A 358 GLY A 357 ASP A 196	None	0.99A	5a06D-5fl7A: undetectable	5a06D-5fl7A: 23.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B8H_A_PAUA302_0 (TYPE III PANTOTHENATE KINASE)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 12	VAL D 172 LEU D 462 GLY D 168 ASP D 173 ILE D 205	None	1.30A	5b8hA-5fl7D: undetectable 5b8hB-5fl7D: undetectable	5b8hA-5fl7D: 20.23 5b8hB-5fl7D: 20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTA_G_MFXG101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	4 / 7	SER D 384 ASP D 346 ARG D 368 GLY D 369	None	0.72A	5btaA-5fl7D: undetectable 5btaC-5fl7D: undetectable 5btaD-5fl7D: undetectable	5btaA-5fl7D: 23.82 5btaC-5fl7D: 23.82 5btaD-5fl7D: 20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BTF_F_GFNF101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCAT GACC)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	4 / 7	SER D 384 ASP D 346 ARG D 368 GLY D 369	None	0.78A	5btfA-5fl7D: undetectable 5btfB-5fl7D: 1.6 5btfC-5fl7D: undetectable	5btfA-5fl7D: 23.82 5btfB-5fl7D: 20.70 5btfC-5fl7D: 23.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_B_BO2B201_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-1)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	5 / 11	SER A 298 THR A 199 THR A 202 GLY A 195 THR A 355	None ATP A 600 (-4.9A) MG A 601 ( 2.8A) None None	1.48A	5bxnV-5fl7A: undetectable 5bxnb-5fl7A: undetectable	5bxnV-5fl7A: 19.41 5bxnb-5fl7A: 16.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CDQ_F_MFXF2101_1 (DNA GYRASE SUBUNIT A DNA GYRASE SUBUNIT B,DNA GYRASE SUBUNIT B)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	4 / 6	SER D 384 ASP D 346 ARG D 368 GLY D 369	None	0.80A	5cdqA-5fl7D: undetectable 5cdqC-5fl7D: undetectable 5cdqD-5fl7D: undetectable	5cdqA-5fl7D: 24.57 5cdqC-5fl7D: 24.57 5cdqD-5fl7D: 17.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5EWZ_B_BEZB301_0 (14-3-3 PROTEIN ZETA/DELTA)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	3 / 3	MET A 307 GLN A 306 ARG A 305	None	0.78A	5ewzB-5fl7A: undetectable	5ewzB-5fl7A: 21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H5F_A_SAMA301_0 (PROTEIN ARGININE N-METHYLTRANSFERASE SFM1)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 12	LEU D 175 PRO D 177 ASP D 392 LEU D 174 ALA D 402	None	1.17A	5h5fA-5fl7D: undetectable	5h5fA-5fl7D: 19.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M35_B_BEZB302_0 (14-3-3 PROTEIN ZETA/DELTA)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	3 / 3	MET A 307 GLN A 306 ARG A 305	None	0.78A	5m35B-5fl7A: undetectable	5m35B-5fl7A: 20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M36_A_BEZA303_0 (14-3-3 PROTEIN ZETA/DELTA)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	3 / 3	MET A 307 GLN A 306 ARG A 305	None	0.79A	5m36A-5fl7A: undetectable	5m36A-5fl7A: 20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M45_J_ACTJ803_0 (ACETONE CARBOXYLASE ALPHA SUBUNIT)	5fl7	ATP SYNTHASE DELTA CHAIN, MITOCHONDRIAL (Yarrowia lipolytica)	4 / 4	GLU H 36 PRO H 31 ILE H 30 LEU H 37	None	1.17A	5m45J-5fl7H: undetectable	5m45J-5fl7H: 11.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ODI_A_ACTA701_0 (HETERODISULFIDE REDUCTASE, SUBUNIT A)	5fl7	ATP SYNTHASE SUBUNIT ALPHA ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica; Yarrowia lipolytica)	3 / 3	LYS A 385 LYS D 413 SER D 414	None	1.07A	5odiA-5fl7A: undetectable	5odiA-5fl7A: 23.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YK2_A_ERYA501_0 (PROBABLE CONSERVED ATP-BINDING PROTEIN ABC TRANSPORTER)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	5 / 11	ARG A 152 GLY A 276 ALA A 278 ILE A 256 VAL A 258	None	1.11A	5yk2A-5fl7A: undetectable	5yk2A-5fl7A: 26.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DLZ_B_CYZB1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 10	LEU D 186 LEU D 360 ASP D 361 ILE D 198 SER D 337	None	1.24A	6dlzB-5fl7D: 4.2 6dlzC-5fl7D: 4.0	6dlzB-5fl7D: 9.77 6dlzC-5fl7D: 9.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DLZ_D_CYZD1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 11	ILE D 198 SER D 337 LEU D 186 LEU D 360 ASP D 361	None	1.25A	6dlzA-5fl7D: 3.0 6dlzD-5fl7D: 4.1	6dlzA-5fl7D: 9.77 6dlzD-5fl7D: 9.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM0_B_CYZB1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 10	LEU D 186 LEU D 360 ASP D 361 ILE D 198 SER D 337	None	1.22A	6dm0B-5fl7D: 4.0 6dm0C-5fl7D: 4.3	6dm0B-5fl7D: 9.77 6dm0C-5fl7D: 9.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM1_B_CYZB1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 10	LEU D 186 LEU D 360 ASP D 361 ILE D 198 SER D 337	None	1.24A	6dm1B-5fl7D: 4.1 6dm1C-5fl7D: 4.1	6dm1B-5fl7D: 9.77 6dm1C-5fl7D: 9.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM1_D_CYZD1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 11	ILE D 198 SER D 337 LEU D 186 LEU D 360 ASP D 361	None	1.24A	6dm1A-5fl7D: 4.2 6dm1D-5fl7D: 4.0	6dm1A-5fl7D: 9.77 6dm1D-5fl7D: 9.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM2_B_CYZB1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 10	LEU D 186 LEU D 360 ASP D 361 ILE D 198 SER D 337	None	1.24A	6dm2B-5fl7D: 2.6 6dm2C-5fl7D: 4.2	6dm2B-5fl7D: 9.77 6dm2C-5fl7D: 9.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6DM2_D_CYZD1302_0 (GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT)	5fl7	ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica)	5 / 10	ILE D 198 SER D 337 LEU D 186 LEU D 360 ASP D 361	None	1.25A	6dm2A-5fl7D: 4.2 6dm2D-5fl7D: 3.0	6dm2A-5fl7D: 9.77 6dm2D-5fl7D: 9.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FN9_A_BEZA302_0 (14-3-3 PROTEIN ZETA/DELTA)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	3 / 3	MET A 307 GLN A 306 ARG A 305	None	0.81A	6fn9A-5fl7A: undetectable	6fn9A-5fl7A: 21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FNA_B_BEZB302_0 (14-3-3 PROTEIN ZETA/DELTA)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	3 / 3	MET A 307 GLN A 306 ARG A 305	None	0.80A	6fnaB-5fl7A: undetectable	6fnaB-5fl7A: 21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6FNB_A_BEZA301_0 (14-3-3 PROTEIN ZETA/DELTA)	5fl7	ATP SYNTHASE SUBUNIT ALPHA (Yarrowia lipolytica)	3 / 3	MET A 307 GLN A 306 ARG A 305	None	0.82A	6fnbA-5fl7A: undetectable	6fnbA-5fl7A: 21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G31_D_ZOLD401_0 (GERANYLGERANYL PYROPHOSPHATE SYNTHASE)	5fl7	ATP SYNTHASE SUBUNIT ALPHA ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica; Yarrowia lipolytica)	4 / 7	ASP D 390 ASP D 392 GLN A 458 GLN A 241	None None ATP A 600 (-3.7A) None	1.25A	6g31D-5fl7D: undetectable	6g31D-5fl7D: 10.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G31_J_ZOLJ401_0 (GERANYLGERANYL PYROPHOSPHATE SYNTHASE)	5fl7	ATP SYNTHASE SUBUNIT ALPHA ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica; Yarrowia lipolytica)	4 / 6	ASP D 390 ASP D 392 GLN A 458 GLN A 241	None None ATP A 600 (-3.7A) None	1.28A	6g31J-5fl7D: undetectable	6g31J-5fl7D: 10.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6G31_L_ZOLL401_0 (GERANYLGERANYL PYROPHOSPHATE SYNTHASE)	5fl7	ATP SYNTHASE SUBUNIT ALPHA ATP SYNTHASE SUBUNIT BETA (Yarrowia lipolytica; Yarrowia lipolytica)	4 / 6	ASP D 390 ASP D 392 GLN A 458 GLN A 241	None None ATP A 600 (-3.7A) None	1.18A	6g31L-5fl7D: undetectable	6g31L-5fl7D: 10.74

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1DIT_P_2PPP1_1","ALPHA-THROMBIN;PEPTIDE INHIBITOR CVS995","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",4,"LEU D 445;ILE D 375;ASP D 380;PRO D 381","None","1.20A","1ditH-5fl7D:0.5;1ditP-5fl7D:undetectable","1ditH-5fl7D:18.07;1ditP-5fl7D:3.37"],["1KT4_A_RTLA184_0","PLASMA RETINOL-BINDING PROTEIN","5fl7","ATP SYNTHASE SUBUNIT ALPHA;ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica;Yarrowia lipolytica",5,"LEU D 382;ALA D 179;ALA D 362;GLN D 406;ARG A 388","None","1.25A","1kt4A-5fl7D:undetectable","1kt4A-5fl7D:16.93"],["1P6K_A_ACTA860_0","NITRIC-OXIDE SYNTHASE, BRAIN","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",4,"GLY A  98;GLN A  96;VAL A  57;ALA A  65","None","0.99A","1p6kA-5fl7A:undetectable","1p6kA-5fl7A:19.72"],["1RMT_D_ADND1504_1","CLASS B ACID PHOSPHATASE","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",4,"ASP D 380;LEU D 348;ASP D 346;THR D 363","None","0.86A","1rmtD-5fl7D:undetectable","1rmtD-5fl7D:20.25"],["1XL6_B_SPMB3001_1","INWARD RECTIFIER POTASSIUM CHANNEL;INWARD RECTIFIER POTASSIUM CHANNEL","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",4,"TYR A 304;ALA A 266;TYR A 270;GLN A 156","None","1.12A","1xl6A-5fl7A:undetectable;1xl6B-5fl7A:undetectable","1xl6A-5fl7A:21.10;1xl6B-5fl7A:21.10"],["1XOQ_B_ROFB501_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",3,"MET A 409;ASN A 211;GLN A 456","None","1.02A","1xoqB-5fl7A:undetectable","1xoqB-5fl7A:21.02"],["2FXD_A_DR7A102_2","POL PROTEIN;POL PROTEIN","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",4,"ALA A 251;ASP A 250;GLY A 131;ILE A 256","None","0.74A","2fxdB-5fl7A:undetectable","2fxdB-5fl7A:10.25"],["2Q7K_A_TESA304_1","ANDROGEN RECEPTOR","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",5,"LEU A 271;LEU A 268;MET A 307;VAL A 100;LEU A  90","None","1.31A","2q7kA-5fl7A:undetectable","2q7kA-5fl7A:19.52"],["2Q8H_A_TF4A438_1","[PYRUVATE DEHYDROGENASE [LIPOAMIDE]] KINASE ISOZYME 1","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"LEU D 248;ILE D 238;ARG D 125;ILE D 126;ARG D 137","None","1.49A","2q8hA-5fl7D:undetectable","2q8hA-5fl7D:22.94"],["2V0Z_O_C41O1327_2","RENIN","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",4,"SER A 396;THR A 372;PRO A 351;LEU A 297","None","1.10A","2v0zO-5fl7A:undetectable","2v0zO-5fl7A:20.70"],["2WEK_A_DIFA1375_1","ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING PROTEIN 2","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",3,"LEU D 409;TYR D 412;GLN D 416","None","0.75A","2wekA-5fl7D:undetectable","2wekA-5fl7D:24.72"],["2ZJ0_A_2FAA500_2","ADENOSYLHOMOCYSTEINASE","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",4,"GLN D 313;THR D 315;HIS D 149;LEU D 265","None","1.38A","2zj0A-5fl7D:undetectable","2zj0A-5fl7D:23.59"],["3A51_B_VDYB6178_1","VITAMIN D HYDROXYLASE","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",5,"THR A 372;LEU A 332;ILE A 353;VAL A 232;PRO A 273","None","1.42A","3a51B-5fl7A:undetectable","3a51B-5fl7A:21.43"],["3BGD_A_PM6A302_1","THIOPURINE S-METHYLTRANSFERASE","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",4,"THR A 174;GLN A 212;LEU A 350;LEU A 291","None","1.15A","3bgdA-5fl7A:2.9","3bgdA-5fl7A:18.22"],["3E9X_A_NIMA1_1","LACTOTRANSFERRIN'","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",4,"GLU D 200;GLY D 168;THR D 167;GLU D 166","None","1.08A","3e9xA-5fl7D:undetectable","3e9xA-5fl7D:21.25"],["3HJO_A_EAAA211_1","GLUTATHIONE S-TRANSFERASE P","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",4,"VAL D 214;VAL D 118;ILE D 327;GLY D 267","None","0.95A","3hjoA-5fl7D:undetectable","3hjoA-5fl7D:20.46"],["3K37_A_BCZA468_1","NEURAMINIDASE","5fl7","ATP SYNTHASE SUBUNIT ALPHA;ATP SYNTHASE SUBUNIT BETA;ATP SYNTHASE SUBUNIT GAMMA CHAIN, MITOCHONDRIAL","Yarrowia lipolytica;Yarrowia lipolytica;Yarrowia lipolytica",3,"ASP D 347;ARG G  25;ARG A 197","None","1.03A","3k37A-5fl7D:undetectable","3k37A-5fl7D:21.58"],["3KKZ_B_SAMB302_0","UNCHARACTERIZED PROTEIN Q5LES9","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"GLY D 119;GLY D 267;PHE D 215;LEU D 248;ALA D 271","None","1.09A","3kkzB-5fl7D:undetectable","3kkzB-5fl7D:19.69"],["3OWX_B_XRAB233_1","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE];RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",5,"VAL A 468;PHE A 494;PHE A 530;GLY A 474;GLY A 477","None","1.37A","3owxA-5fl7A:undetectable;3owxB-5fl7A:undetectable","3owxA-5fl7A:17.96;3owxB-5fl7A:17.96"],["3QXY_A_SAMA6734_0","N-LYSINE METHYLTRANSFERASE SETD6","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",5,"VAL A 412;ALA A 413;GLY A 414;ALA A 404;LEU A 515","None","1.18A","3qxyA-5fl7A:undetectable","3qxyA-5fl7A:23.09"],["3RC0_A_SAMA484_0","N-LYSINE METHYLTRANSFERASE SETD6","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",5,"VAL A 412;ALA A 413;GLY A 414;ALA A 404;LEU A 515","None","1.15A","3rc0A-5fl7A:undetectable","3rc0A-5fl7A:23.09"],["3RC0_B_SAMB480_0","N-LYSINE METHYLTRANSFERASE SETD6","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",5,"VAL A 412;ALA A 413;GLY A 414;ALA A 404;LEU A 515","None","1.14A","3rc0B-5fl7A:undetectable","3rc0B-5fl7A:23.09"],["3WFA_B_EDTB802_0","ALPHA-GLUCOSIDASE","5fl7","ATP SYNTHASE SUBUNIT ALPHA;ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica;Yarrowia lipolytica",4,"ARG A 106;ASP D 109;ASN D  65;LYS A 109","None","1.19A","3wfaA-5fl7A:undetectable;3wfaB-5fl7A:undetectable","3wfaA-5fl7A:23.06;3wfaB-5fl7A:23.06"],["3WRI_A_CAMA502_0","CAMPHOR 5-MONOOXYGENASE","5fl7","ATP SYNTHASE SUBUNIT BETA;ATP SYNTHASE SUBUNIT GAMMA CHAIN, MITOCHONDRIAL","Yarrowia lipolytica;Yarrowia lipolytica",4,"LEU G 292;GLY D 304;ILE D  47;VAL D  50","None","0.80A","3wriA-5fl7G:undetectable","3wriA-5fl7G:19.72"],["3WRI_B_CAMB502_0","CAMPHOR 5-MONOOXYGENASE","5fl7","ATP SYNTHASE SUBUNIT BETA;ATP SYNTHASE SUBUNIT GAMMA CHAIN, MITOCHONDRIAL","Yarrowia lipolytica;Yarrowia lipolytica",4,"LEU G 292;GLY D 304;ILE D  47;VAL D  50","None","0.81A","3wriB-5fl7G:undetectable","3wriB-5fl7G:19.72"],["3WRK_A_CAMA502_0","CAMPHOR 5-MONOOXYGENASE","5fl7","ATP SYNTHASE SUBUNIT BETA;ATP SYNTHASE SUBUNIT GAMMA CHAIN, MITOCHONDRIAL","Yarrowia lipolytica;Yarrowia lipolytica",4,"LEU G 292;GLY D 304;ILE D  47;VAL D  50","None","0.83A","3wrkA-5fl7G:undetectable","3wrkA-5fl7G:19.72"],["3WRK_D_CAMD502_0","CAMPHOR 5-MONOOXYGENASE","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",4,"PHE A 294;LEU A 347;GLY A 280;VAL A 258","None","0.94A","3wrkD-5fl7A:undetectable","3wrkD-5fl7A:21.14"],["4A9K_A_TYLA2200_1","CREB-BINDING PROTEIN","5fl7","ATP SYNTHASE DELTA CHAIN, MITOCHONDRIAL","Yarrowia lipolytica",4,"VAL H  84;LEU H  50;ILE H  69;VAL H  28","None","0.92A","4a9kA-5fl7H:undetectable","4a9kA-5fl7H:20.71"],["4AN2_A_EUIA1382_2","DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",4,"ASN D 404;SER D 386;LEU D 389;THR D 408","None","1.36A","4an2A-5fl7D:undetectable","4an2A-5fl7D:19.77"],["4BQF_A_QPSA951_1","ALPHA-GLUCAN PHOSPHORYLASE 2, CYTOSOLIC","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",4,"MET A 338;GLY A 345;ARG A 165;GLU A 281","None","1.46A","4bqfA-5fl7A:undetectable","4bqfA-5fl7A:21.32"],["4EIL_D_FOLD703_0","BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"VAL D 401;ASP D 477;SER D 471;PHE D 488;VAL D 405","None","1.24A","4eilD-5fl7D:undetectable","4eilD-5fl7D:24.72"],["4FGK_A_0TXA304_0","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",5,"GLY A 474;GLY A 477;VAL A 468;PHE A 494;PHE A 530","None","1.39A","4fgkA-5fl7A:undetectable;4fgkB-5fl7A:undetectable","4fgkA-5fl7A:17.96;4fgkB-5fl7A:17.96"],["4KYA_B_FOLB703_0","BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"VAL D 401;ASP D 477;SER D 471;PHE D 488;VAL D 405","None","1.28A","4kyaB-5fl7D:undetectable","4kyaB-5fl7D:24.72"],["4KYA_C_FOLC703_0","BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"VAL D 401;ASP D 477;SER D 471;PHE D 488;VAL D 405","None","1.34A","4kyaC-5fl7D:undetectable","4kyaC-5fl7D:24.72"],["4KYA_D_FOLD703_0","BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"VAL D 401;ASP D 477;SER D 471;PHE D 488;VAL D 405","None","1.26A","4kyaD-5fl7D:undetectable","4kyaD-5fl7D:24.72"],["4KYA_F_FOLF703_0","BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"VAL D 401;ASP D 477;SER D 471;PHE D 488;VAL D 405","None","1.23A","4kyaF-5fl7D:undetectable","4kyaF-5fl7D:24.72"],["4KYA_G_FOLG703_0","BIFUNCTIONAL DIHYDROFOLATE REDUCTASE-THYMIDYLATE SYNTHASE","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"VAL D 401;ASP D 477;SER D 471;PHE D 488;VAL D 405","None","1.34A","4kyaG-5fl7D:undetectable","4kyaG-5fl7D:24.72"],["4O5F_A_PAUA301_0","TYPE III PANTOTHENATE KINASE","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"VAL D 172;LEU D 462;GLY D 168;ASP D 173;ILE D 205","None","1.31A","4o5fA-5fl7D:undetectable;4o5fB-5fl7D:undetectable","4o5fA-5fl7D:22.76;4o5fB-5fl7D:22.76"],["4QW3_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",5,"SER A 298;THR A 199;THR A 202;GLY A 195;THR A 355","None;ATP A 600 (-4.9A); MG A 601 ( 2.8A);None;None","1.45A","4qw3V-5fl7A:undetectable;4qw3b-5fl7A:undetectable","4qw3V-5fl7A:19.84;4qw3b-5fl7A:16.76"],["4QW3_N_BO2N201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",5,"SER A 298;THR A 199;THR A 202;GLY A 195;THR A 355","None;ATP A 600 (-4.9A); MG A 601 ( 2.8A);None;None","1.46A","4qw3H-5fl7A:undetectable;4qw3N-5fl7A:undetectable","4qw3H-5fl7A:19.84;4qw3N-5fl7A:16.76"],["4UY8_7_TRP71002_0","TRYPTOPHANASE","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",4,"ILE D 205;ASN D 204;ILE D 169;VAL D 172","None","1.26A","4uy87-5fl7D:undetectable","4uy87-5fl7D:9.35"],["4XP4_A_COCA706_1","DOPAMINE TRANSPORTER","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"ASP D 287;ALA D 340;ASP D 227;GLY D 219;GLY D 225"," MG D 601 ( 4.8A);None;None;None;None","1.27A","4xp4A-5fl7D:undetectable","4xp4A-5fl7D:24.75"],["4ZJO_A_ERYA1101_0","MULTIDRUG EFFLUX PUMP SUBUNIT ACRB","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"ALA D 295;ASP D 287;GLU D 224;GLU D 220;THR D 195","None; MG D 601 ( 4.8A); MG D 601 ( 3.8A); MG D 601 ( 4.9A); MG D 601 ( 3.1A)","1.48A","4zjoA-5fl7D:undetectable","4zjoA-5fl7D:20.88"],["4ZVM_B_DM2B303_1","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE];RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",5,"VAL A 468;PHE A 494;PHE A 530;GLY A 474;GLY A 477","None","1.34A","4zvmA-5fl7A:undetectable;4zvmB-5fl7A:undetectable","4zvmA-5fl7A:18.05;4zvmB-5fl7A:18.05"],["5A06_D_SORD1341_0","ALDOSE-ALDOSE OXIDOREDUCTASE","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",4,"GLU A 379;GLY A 358;GLY A 357;ASP A 196","None","0.99A","5a06D-5fl7A:undetectable","5a06D-5fl7A:23.15"],["5B8H_A_PAUA302_0","TYPE III PANTOTHENATE KINASE","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"VAL D 172;LEU D 462;GLY D 168;ASP D 173;ILE D 205","None","1.30A","5b8hA-5fl7D:undetectable;5b8hB-5fl7D:undetectable","5b8hA-5fl7D:20.23;5b8hB-5fl7D:20.23"],["5BTA_G_MFXG101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",4,"SER D 384;ASP D 346;ARG D 368;GLY D 369","None","0.72A","5btaA-5fl7D:undetectable;5btaC-5fl7D:undetectable;5btaD-5fl7D:undetectable","5btaA-5fl7D:23.82;5btaC-5fl7D:23.82;5btaD-5fl7D:20.70"],["5BTF_F_GFNF101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B;DNA GYRASE SUBUNIT A;DNA SUBSTRATE 24-MER TTACGTGCATAGTCATTCATGACC","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",4,"SER D 384;ASP D 346;ARG D 368;GLY D 369","None","0.78A","5btfA-5fl7D:undetectable;5btfB-5fl7D:1.6;5btfC-5fl7D:undetectable","5btfA-5fl7D:23.82;5btfB-5fl7D:20.70;5btfC-5fl7D:23.82"],["5BXN_B_BO2B201_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-1","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",5,"SER A 298;THR A 199;THR A 202;GLY A 195;THR A 355","None;ATP A 600 (-4.9A); MG A 601 ( 2.8A);None;None","1.48A","5bxnV-5fl7A:undetectable;5bxnb-5fl7A:undetectable","5bxnV-5fl7A:19.41;5bxnb-5fl7A:16.76"],["5CDQ_F_MFXF2101_1","DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT A;DNA GYRASE SUBUNIT B,DNA GYRASE SUBUNIT B","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",4,"SER D 384;ASP D 346;ARG D 368;GLY D 369","None","0.80A","5cdqA-5fl7D:undetectable;5cdqC-5fl7D:undetectable;5cdqD-5fl7D:undetectable","5cdqA-5fl7D:24.57;5cdqC-5fl7D:24.57;5cdqD-5fl7D:17.42"],["5EWZ_B_BEZB301_0","14-3-3 PROTEIN ZETA\/DELTA","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",3,"MET A 307;GLN A 306;ARG A 305","None","0.78A","5ewzB-5fl7A:undetectable","5ewzB-5fl7A:21.01"],["5H5F_A_SAMA301_0","PROTEIN ARGININE N-METHYLTRANSFERASE SFM1","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"LEU D 175;PRO D 177;ASP D 392;LEU D 174;ALA D 402","None","1.17A","5h5fA-5fl7D:undetectable","5h5fA-5fl7D:19.14"],["5M35_B_BEZB302_0","14-3-3 PROTEIN ZETA\/DELTA","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",3,"MET A 307;GLN A 306;ARG A 305","None","0.78A","5m35B-5fl7A:undetectable","5m35B-5fl7A:20.83"],["5M36_A_BEZA303_0","14-3-3 PROTEIN ZETA\/DELTA","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",3,"MET A 307;GLN A 306;ARG A 305","None","0.79A","5m36A-5fl7A:undetectable","5m36A-5fl7A:20.83"],["5M45_J_ACTJ803_0","ACETONE CARBOXYLASE ALPHA SUBUNIT","5fl7","ATP SYNTHASE DELTA CHAIN, MITOCHONDRIAL","Yarrowia lipolytica",4,"GLU H  36;PRO H  31;ILE H  30;LEU H  37","None","1.17A","5m45J-5fl7H:undetectable","5m45J-5fl7H:11.48"],["5ODI_A_ACTA701_0","HETERODISULFIDE REDUCTASE, SUBUNIT A","5fl7","ATP SYNTHASE SUBUNIT ALPHA;ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica;Yarrowia lipolytica",3,"LYS A 385;LYS D 413;SER D 414","None","1.07A","5odiA-5fl7A:undetectable","5odiA-5fl7A:23.32"],["5YK2_A_ERYA501_0","PROBABLE CONSERVED ATP-BINDING PROTEIN ABC TRANSPORTER","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",5,"ARG A 152;GLY A 276;ALA A 278;ILE A 256;VAL A 258","None","1.11A","5yk2A-5fl7A:undetectable","5yk2A-5fl7A:26.30"],["6DLZ_B_CYZB1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"LEU D 186;LEU D 360;ASP D 361;ILE D 198;SER D 337","None","1.24A","6dlzB-5fl7D:4.2;6dlzC-5fl7D:4.0","6dlzB-5fl7D:9.77;6dlzC-5fl7D:9.77"],["6DLZ_D_CYZD1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"ILE D 198;SER D 337;LEU D 186;LEU D 360;ASP D 361","None","1.25A","6dlzA-5fl7D:3.0;6dlzD-5fl7D:4.1","6dlzA-5fl7D:9.77;6dlzD-5fl7D:9.77"],["6DM0_B_CYZB1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"LEU D 186;LEU D 360;ASP D 361;ILE D 198;SER D 337","None","1.22A","6dm0B-5fl7D:4.0;6dm0C-5fl7D:4.3","6dm0B-5fl7D:9.77;6dm0C-5fl7D:9.77"],["6DM1_B_CYZB1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"LEU D 186;LEU D 360;ASP D 361;ILE D 198;SER D 337","None","1.24A","6dm1B-5fl7D:4.1;6dm1C-5fl7D:4.1","6dm1B-5fl7D:9.77;6dm1C-5fl7D:9.77"],["6DM1_D_CYZD1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"ILE D 198;SER D 337;LEU D 186;LEU D 360;ASP D 361","None","1.24A","6dm1A-5fl7D:4.2;6dm1D-5fl7D:4.0","6dm1A-5fl7D:9.77;6dm1D-5fl7D:9.77"],["6DM2_B_CYZB1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"LEU D 186;LEU D 360;ASP D 361;ILE D 198;SER D 337","None","1.24A","6dm2B-5fl7D:2.6;6dm2C-5fl7D:4.2","6dm2B-5fl7D:9.77;6dm2C-5fl7D:9.77"],["6DM2_D_CYZD1302_0","GLUTAMATE RECEPTOR 2,VOLTAGE-DEPENDENT CALCIUM CHANNEL GAMMA-2 SUBUNIT","5fl7","ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica",5,"ILE D 198;SER D 337;LEU D 186;LEU D 360;ASP D 361","None","1.25A","6dm2A-5fl7D:4.2;6dm2D-5fl7D:3.0","6dm2A-5fl7D:9.77;6dm2D-5fl7D:9.77"],["6FN9_A_BEZA302_0","14-3-3 PROTEIN ZETA\/DELTA","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",3,"MET A 307;GLN A 306;ARG A 305","None","0.81A","6fn9A-5fl7A:undetectable","6fn9A-5fl7A:21.01"],["6FNA_B_BEZB302_0","14-3-3 PROTEIN ZETA\/DELTA","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",3,"MET A 307;GLN A 306;ARG A 305","None","0.80A","6fnaB-5fl7A:undetectable","6fnaB-5fl7A:21.01"],["6FNB_A_BEZA301_0","14-3-3 PROTEIN ZETA\/DELTA","5fl7","ATP SYNTHASE SUBUNIT ALPHA","Yarrowia lipolytica",3,"MET A 307;GLN A 306;ARG A 305","None","0.82A","6fnbA-5fl7A:undetectable","6fnbA-5fl7A:21.01"],["6G31_D_ZOLD401_0","GERANYLGERANYL PYROPHOSPHATE SYNTHASE","5fl7","ATP SYNTHASE SUBUNIT ALPHA;ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica;Yarrowia lipolytica",4,"ASP D 390;ASP D 392;GLN A 458;GLN A 241","None;None;ATP A 600 (-3.7A);None","1.25A","6g31D-5fl7D:undetectable","6g31D-5fl7D:10.74"],["6G31_J_ZOLJ401_0","GERANYLGERANYL PYROPHOSPHATE SYNTHASE","5fl7","ATP SYNTHASE SUBUNIT ALPHA;ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica;Yarrowia lipolytica",4,"ASP D 390;ASP D 392;GLN A 458;GLN A 241","None;None;ATP A 600 (-3.7A);None","1.28A","6g31J-5fl7D:undetectable","6g31J-5fl7D:10.74"],["6G31_L_ZOLL401_0","GERANYLGERANYL PYROPHOSPHATE SYNTHASE","5fl7","ATP SYNTHASE SUBUNIT ALPHA;ATP SYNTHASE SUBUNIT BETA","Yarrowia lipolytica;Yarrowia lipolytica",4,"ASP D 390;ASP D 392;GLN A 458;GLN A 241","None;None;ATP A 600 (-3.7A);None","1.18A","6g31L-5fl7D:undetectable","6g31L-5fl7D:10.74"]]